Pages that link to "Q36900010"
Jump to navigation
Jump to search
The following pages link to HIV-1 drug resistance mutations: an updated framework for the second decade of HAART (Q36900010):
Displaying 50 items.
- The Road Less Traveled: HIV's Use of Alternative Routes through Cellular Pathways (Q27027607) (← links)
- A Single-Cell Platform for Monitoring Viral Proteolytic Cleavage in Different Cellular Compartments (Q27468663) (← links)
- Functional and structural characterization of the integrase from the prototype foamy virus (Q27653000) (← links)
- Structure-Based Design, Synthesis, and Structure−Activity Relationship Studies of HIV-1 Protease Inhibitors Incorporating Phenyloxazolidinones (Q27665164) (← links)
- Crystallographic and Functional Analysis of the ESCRT-I /HIV-1 Gag PTAP Interaction (Q27665841) (← links)
- Potent Antiviral HIV-1 Protease Inhibitor GRL-02031 Adapts to the Structures of Drug Resistant Mutants with Its P1′-Pyrrolidinone Ring (Q27677939) (← links)
- HIV-1 Protease-Substrate Coevolution in Nelfinavir Resistance (Q27683192) (← links)
- Effects of Hinge Region Natural Polymorphisms on Human Immunodeficiency Virus-1 Protease Structure, Dynamics and Drug-Pressure Evolution (Q27727967) (← links)
- Only slight impact of predicted replicative capacity for therapy response prediction (Q28472749) (← links)
- Prevalence of transmitted drug resistance and impact of transmitted resistance on treatment success in the German HIV-1 Seroconverter Cohort (Q28475698) (← links)
- National prevalence and trends of HIV transmitted drug resistance in Mexico (Q28477977) (← links)
- Identification of drug resistant mutations in HIV-1 CRF07_BC variants selected by nevirapine in vitro (Q28483726) (← links)
- Significantly improved HIV inhibitor efficacy prediction employing proteochemometric models generated from antivirogram data (Q28486299) (← links)
- HIV-1 pol diversity among female bar and hotel workers in Northern Tanzania (Q28540536) (← links)
- Integrated analysis of residue coevolution and protein structures capture key protein sectors in HIV-1 proteins (Q28543396) (← links)
- Trends in Prevalence of HIV-1 Drug Resistance in a Public Clinic in Maputo, Mozambique (Q28546341) (← links)
- Strong Selection Significantly Increases Epistatic Interactions in the Long-Term Evolution of a Protein (Q28551065) (← links)
- Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients (Q28728304) (← links)
- Adaptive evolution by recombination is not associated with increased mutation rates in Maize streak virus (Q31109744) (← links)
- Host sequence motifs shared by HIV predict response to antiretroviral therapy (Q33486144) (← links)
- Pairwise and higher-order correlations among drug-resistance mutations in HIV-1 subtype B protease (Q33503921) (← links)
- Transmitted drug resistance in nonsubtype B HIV-1 infection (Q33567164) (← links)
- Inhibition of HIV-1 replication by isoxazolidine and isoxazole sulfonamides (Q33582517) (← links)
- Minority variants associated with transmitted and acquired HIV-1 nonnucleoside reverse transcriptase inhibitor resistance: implications for the use of second-generation nonnucleoside reverse transcriptase inhibitors (Q33601530) (← links)
- Impact of Y181C and/or H221Y mutation patterns of HIV-1 reverse transcriptase on phenotypic resistance to available non-nucleoside and nucleoside inhibitors in China (Q33624190) (← links)
- Error correction of next-generation sequencing data and reliable estimation of HIV quasispecies (Q33645217) (← links)
- Use of Proviral DNA to Investigate Virus Resistance Mutations in HIV-infected Zimbabweans (Q33668468) (← links)
- Inference of Epistatic Effects Leading to Entrenchment and Drug Resistance in HIV-1 Protease. (Q33698683) (← links)
- Genetic analysis and natural polymorphisms in HIV-1 gp41 isolates from Maputo City, Mozambique (Q33713862) (← links)
- Combination of V106I and V179D polymorphic mutations in human immunodeficiency virus type 1 reverse transcriptase confers resistance to efavirenz and nevirapine but not etravirine (Q33768822) (← links)
- Constrained patterns of covariation and clustering of HIV-1 non-nucleoside reverse transcriptase inhibitor resistance mutations (Q33902540) (← links)
- Virological and immunological response in HIV-1-infected patients with multiple treatment failures receiving raltegravir and optimized background therapy, ANRS CO3 Aquitaine Cohort (Q33910771) (← links)
- Co-lethality studied as an asset against viral drug escape: the HIV protease case (Q33968760) (← links)
- Cross-validated stepwise regression for identification of novel non-nucleoside reverse transcriptase inhibitor resistance associated mutations (Q34038440) (← links)
- HIV multi-drug resistance at first-line antiretroviral failure and subsequent virological response in Asia (Q34072721) (← links)
- Inhibitory effect of aqueous Dandelion extract on HIV-1 replication and reverse transcriptase activity (Q34073041) (← links)
- A flavonoid, luteolin, cripples HIV-1 by abrogation of tat function (Q34091121) (← links)
- A multifaceted analysis of HIV-1 protease multidrug resistance phenotypes (Q34102058) (← links)
- Secondary integrase resistance mutations found in HIV-1 minority quasispecies in integrase therapy-naive patients have little or no effect on susceptibility to integrase inhibitors. (Q34108775) (← links)
- Analysis of high-depth sequence data for studying viral diversity: a comparison of next generation sequencing platforms using Segminator II. (Q34207464) (← links)
- Gyrase B inhibitor impairs HIV-1 replication by targeting Hsp90 and the capsid protein (Q34385711) (← links)
- Comparison of the Mechanisms of Drug Resistance among HIV, Hepatitis B, and Hepatitis C (Q34489239) (← links)
- Dose–response curve slope is a missing dimension in the analysis of HIV-1 drug resistance (Q34937254) (← links)
- Pharmacokinetics and Pharmacodynamics of TBR-652, a Novel CCR5 Antagonist, in HIV-1-Infected, Antiretroviral Treatment-Experienced, CCR5 Antagonist-Naïve Patients (Q35004830) (← links)
- The evolution of HIV-1 reverse transcriptase in route to acquisition of Q151M multi-drug resistance is complex and involves mutations in multiple domains (Q35042225) (← links)
- Sequence and structure based models of HIV-1 protease and reverse transcriptase drug resistance (Q35051539) (← links)
- Predictors for the emergence of the 2 multi-nucleoside/nucleotide resistance mutations 69 insertion and Q151M and their impact on clinical outcome in the Swiss HIV cohort study (Q35057734) (← links)
- Major HIV resistance mutations in untreated Romanian patients. (Q35071197) (← links)
- Protection against Rectal Transmission of an Emtricitabine-Resistant Simian/Human Immunodeficiency Virus SHIV162p3M184VMutant by Intermittent Prophylaxis with Truvada (Q35140323) (← links)
- A quantitative comparison of anti-HIV gene therapy delivered to hematopoietic stem cells versus CD4+ T cells (Q35191116) (← links)